|
Market Closed -
Nasdaq Stockholm
00:00:00 29/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 6.500 SEK | -0.15% |
|
-3.85% | +16.07% |
| 09-16 | Mendus Launches Early-stage Trial for Acute Myeloid Leukemia Treatment Combo | MT |
| 09-16 | Mendus launches Phase 1b study with vididencel | FW |
| Market Cap | 431M 43.29M 38.07M 36M 32.65M 61.32M 4.16B 61.68M 166M 2.12B 163M 159M 6.81B | P/E 2026 * |
-4.27x | P/E 2027 * | -6.49x |
|---|---|---|---|---|---|
| Enterprise Value | 452M 45.43M 39.95M 37.78M 34.27M 64.36M 4.36B 64.73M 175M 2.23B 171M 167M 7.15B | EV / Sales 2026 * |
59.3x | EV / Sales 2027 * | 1.5x |
| Free-Float |
34.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMMU | Delayed | |
Deutsche Boerse AG
| 1YG0 | Delayed | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| 1YG0 | Delayed | |
|
CBOE
| IMMUs | Real-time | |
|
Boerse Muenchen
| 1YG0 | Real-time |
Last Transcript: Mendus AB
| 1 day | -0.15% | ||
| 1 week | -3.85% | ||
| Current month | -7.14% | ||
| 1 month | -7.67% | ||
| 3 months | +4.84% | ||
| 6 months | +32.11% | ||
| Current year | +16.07% |
| 1 week | 6.41 |  | 6.77 |
| 1 month | 6 | | 8.49 |
| Current year | 3.86 | | 8.49 |
| 1 year | 3.86 | | 8.49 |
| 3 years | 3.86 | | 16.38 |
| 5 years | 3.86 | | 126.8 |
| 10 years | 3.86 | | 640 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Manting
CEO | Chief Executive Officer | 54 | 16/03/2021 |
| Chief Executive Officer | 76 | 13/12/2019 | |
Lotta Ferm
DFI | Director of Finance/CFO | 60 | 28/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Christine Lind
CHM | Chairman | 52 | 22/01/2021 |
Helén Tuvesson
BRD | Director/Board Member | 64 | 01/01/2020 |
| Director/Board Member | 74 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/2/22 | Buy | Chief Technology Officer | 10,000 | 0.0050% | ||
| 24/2/22 | Buy | Chief Financial Officer | 10,000 | 0.0050% | ||
| 24/2/22 | Buy | Chief Financial Officer | 10,000 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | -3.85% | -2.99% | -24.15% | 43.53M | |
| +2.64% | +6.45% | +11.87% | +38.40% | 47.97B | |
| +0.22% | +0.40% | +50.91% | +37.06% | 44.5B | |
| -1.58% | +4.66% | +359.34% | +614.38% | 43.93B | |
| +1.70% | +0.36% | +12.56% | +99.27% | 41.03B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.85B | |
| -0.48% | -1.32% | +23.98% | +150.01% | 17.27B | |
| +0.08% | +9.03% | +8.41% | - | 15.34B | |
| +1.76% | +0.85% | +29.13% | +48.42% | 15.3B | |
| +1.97% | -3.17% | - | - | 14.82B | |
| Average | +0.67% | +1.55% | +55.38% | +126.28% | 27.01B | |
| Weighted average by Cap. | +0.74% | +1.89% | +79.45% | +163.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.63M 767K 674K 638K 578K 1.09M 73.58M 1.09M 2.95M 37.55M 2.88M 2.82M 121M | 172M 17.29M 15.21M 14.38M 13.04M 24.49M 1.66B 24.64M 66.49M 847M 64.91M 63.51M 2.72B |
| Net income | -99.17M -9.96M -8.76M -8.28M -7.51M -14.11M -956M -14.19M -38.3M -488M -37.39M -36.58M -1.57B | -33.34M -3.35M -2.94M -2.78M -2.53M -4.74M -321M -4.77M -12.88M -164M -12.57M -12.3M -527M |
| Net Debt | 21.31M 2.14M 1.88M 1.78M 1.61M 3.03M 205M 3.05M 8.23M 105M 8.04M 7.86M 337M | -172M -17.27M -15.19M -14.37M -13.03M -24.47M -1.66B -24.61M -66.43M -846M -64.85M -63.45M -2.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | SEK 6.500 | -0.15% | 6,295 |
| 25/09/26 | SEK 6.510 | -3.84% | 12,876 |
| 24/09/26 | SEK 6.770 | +0.59% | 14,780 |
| 23/09/26 | SEK 6.730 | -0.15% | 7,390 |
| 22/09/26 | SEK 6.740 | -0.30% | 2,293 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMU Stock
Select your edition
All financial news and data tailored to specific country editions
